The Patent Finder

Novuspharma S.P.A.

Also on record
Records under this name other than patents Novuspharma S.P.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Novuspharma S.P.A.

PatentTitleStatus Expires Confidence
US 6,596,889Nitrates of bis-platinum complexes with polyamine ligands
Term ended
Term ended Feb 13, 2022 · From the USPTO record
Term endedTerm ended Feb 13, 2022From the USPTO record
US 6,034,0922-[2-[(2-hydroxyethyl)amino]ethy [ l]-5-[[2-methylamino)ethyl]amino]indazolo4,3-gh]isoquinolin-6(2H)-one as antitumor agent
Term ended
Term ended Jun 22, 2018 · From the USPTO record
Term endedTerm ended Jun 22, 2018From the USPTO record
US 6,207,655Bis-phosphonate confugates with alkylating moieties having antitumor activity
Lapsed on the fee record
Ended Mar 27, 2013 · From the USPTO record
Lapsed on the fee recordEnded Mar 27, 2013From the USPTO record
US 7,449,197Liposome formulation of 6,9-bis[(2-aminoethyl)-amino]benzo[g]isoquinoline-5, 10-dione dimaleate
Formerly held
Lapsed on the fee record
Ended Nov 11, 2012 · From the USPTO record
Lapsed on the fee recordEnded Nov 11, 2012From the USPTO record
US 6,753,3422-(1h-indol-3-yl)-2-oxo-acetamides with antitumor activity
Lapsed on the fee record
Ended Jun 22, 2012 · From the USPTO record
Lapsed on the fee recordEnded Jun 22, 2012From the USPTO record
US 7,189,840Oncosuppressive gene
Lapsed on the fee record
Ended Mar 13, 2011 · From the USPTO record
Lapsed on the fee recordEnded Mar 13, 2011From the USPTO record
US 6,987,1222-(1H-indol-3-yl)-2-oxo-acetic acid amides with antitumor activity
Lapsed on the fee record
Ended Jan 17, 2010 · From the USPTO record
Lapsed on the fee recordEnded Jan 17, 2010From the USPTO record
US 5,506,2326,9-Bis[(2-aminoethyl)amino]benzo[g]isoquinoline-5,10-dione and its dimaleate salt
Term ended
Term ended no later than Apr 9, 2016 · Low confidence
Term endedTerm ended no later than Apr 9, 2016Low confidence
US 5,519,0292-aminoalkyl-5-aminoalkylamino substituted-isoquinoindazole-6(2H)-ones
Term ended
Term ended no later than May 21, 2016 · Low confidence
Term endedTerm ended no later than May 21, 2016Low confidence
US 5,587,3826,9-Bis[(2-aminoethyl) amino]benzo [g]isoquinoline-5,10- dione dimaleate; an aza-anthracenedione with reduced cardiotoxicity
Term ended
Term ended no later than Dec 24, 2016 · Low confidence
Term endedTerm ended no later than Dec 24, 2016Low confidence
10 of 14 patents shown.
Pro members see all 14.
Pro members: see all 14 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited